New Bolton Center Kennett Square, PA
Emergencies & Appointments:
Ryan Hospital Philadelphia, PA

Mason Immunotherapy Research in the News

Contact Mason Immunotherapy

Dr. Nicola Mason, Canine Cancer Studies

Dr. Nicola Mason’s innovative immunotherapeutic approach to treating dogs with cancer uses the patient’s own immune system to target and kill tumor cells.

Dr. Mason:

Patient Stories

Sasha, first dog to receive cancer vaccine

Sasha - First Dog to Receive Cancer Vaccine

Sasha was diagnosed with osteosarcoma, a highly aggressive bone cancer in March of 2012. The prognosis for this disease is guarded at best and dogs that undergo amputation followed by chemotherapy, the standard of care for this disease, have a median survival of only one year. Most dogs die as a result of cancer metastases (spread) to their lungs or other bones.

Sasha finally succumbed to this disease in March 2014, adding another year to her life than expected.


500 Days and Counting

Lewis, an eight-year-old Golden Retriever, qualified for the prestigious 2013 Master National hunt test in Kansas. As part of his final preparation, Lewis ran the first series of a master hunt test before the competition as a confidence builder. He nailed it.


Denali - Treating Canine Cancer Without Amputation

Denali, a 10-year-old Spinone, was the first dog to enroll in Dr. Nicola Mason’s clinical trial for dogs with osteosarcoma who had not undergone amputation. Read Denali's story...